C71T
CANCELLED SECTION 71
03/27/2026
Back to search
Official data from USPTO
MANROS THERAPEUTICS FROM SEA TO PHARMACY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
04/21/2026
Trademark type
Combined
Nice classes
5, 42
Filing date
10/18/2018
Registration date
09/10/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/27/2026
Last transaction
04/21/2026
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
FR
Examiner
LAVACHE, LINDA M
Law office
L60
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of a design comprised of two adjacent incomplete circles that each feature a wave design at the top. A group of small solid circles appears inside each incomplete circle. Below the design is the wording "MANROS" above the word "THERAPEUTICS" with the wording "FROM SEA TO PHARMACY" appearing below "THERAPEUTICS".
Holders and representatives
Holders
M. T. (pessoa física)
Representatives
Jennifer Sheehan Anderson Bridge Intellectual Property Services PL
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical products for the treatment of cystic fibrosispolycystic kidney diseaseDown syndrome and Alzheimer's disease; chemical preparations for medical or pharmaceutical usefor the treatment of cystic fibrosispolycystic kidney diseaseDown syndrome and Alzheimer's disease
Class 42
Scientific research for medical purposes in the fields of cystic fibrosispolycystic kidney diseaseDown syndrome and Alzheimer's disease
Publications
History of USPTO decisions and trademark events.
27 publications found
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
09/10/2024
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
01/31/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
01/09/2020
FIMP
FINAL DISPOSITION PROCESSED
01/09/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
12/10/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
09/10/2019
GPNX
NOTIFICATION PROCESSED BY IB
06/28/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/25/2019
PUBO
PUBLISHED FOR OPPOSITION
06/25/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
06/12/2019
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
06/12/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/05/2019
ALIE
ASSIGNED TO LIE
05/20/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/07/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/06/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/06/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/06/2019
RFNT
REFUSAL PROCESSED BY IB
04/05/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/21/2019
RFRR
REFUSAL PROCESSED BY MPU
03/21/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/12/2019
CNRT
NON-FINAL ACTION WRITTEN
03/11/2019
MAFR
APPLICATION FILING RECEIPT MAILED
03/08/2019
DOCK
ASSIGNED TO EXAMINER
03/04/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/04/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/14/2019
Continuous trademark protection
Get notified about every new filing that threatens MANROS THERAPEUTICS FROM SEA TO PHARMACY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.